HALO
HALOZYME THERAPEUTICS, INC.
Recent 8-K filings for HALO
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 11, 2026 20:06 UTC earnings item 2.02item 9.01
Halozyme Q1 revenue up 42% to $377M; new $1B buyback program
source · HALO on sec.gov